ADVFN Logo
Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

CGTX Cognition Therapeutics Inc

1.945
0.015 (0.78%)
Last Updated: 12:12:51
Delayed by 15 minutes
Company Name Stock Ticker Symbol Market Type
Cognition Therapeutics Inc CGTX NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.015 0.78% 1.945 12:12:51
Open Price Low Price High Price Close Price Prev Close
1.93 1.87 1.97 1.93
more quote information »

Recent News

Date Time Source Heading
3/11/202416:11EDGAR2Form 8-K - Current report
3/11/202416:06EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
2/20/202416:44EDGAR2Form 8-K - Current report
2/20/202416:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/20/202416:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/09/202419:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/19/202415:07EDGAR2Form SC 13G - Statement of acquisition of beneficial..
1/09/202400:15EDGAR2Form EFFECT - Notice of Effectiveness
1/08/202416:11EDGAR2Form 424B4 - Prospectus [Rule 424(b)(4)]
1/04/202416:21EDGAR2Form 8-K - Current report
1/04/202407:30GLOBECognition Therapeutics CEO Issues Letter to Shareholders
12/29/202316:02EDGAR2Form S-3 - Registration statement under Securities Act of..
11/16/202307:30GLOBECognition Therapeutics Releases New Episode of..
11/15/202307:30GLOBECognition Therapeutics Presents Preclinical Data Identifying..
11/13/202317:25EDGAR2Form SC 13D/A - General statement of acquisition of..
11/13/202309:48EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/13/202309:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/07/202307:30GLOBECognition Therapeutics Completes Enrollment in Phase 2 SHINE..
11/02/202307:45EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/02/202307:41EDGAR2Form 8-K - Current report
11/02/202307:30GLOBECognition Therapeutics Reports Third Quarter 2023 Financial..
10/27/202307:30GLOBECognition Therapeutics and Collaborators at Yale and ACTC..
10/24/202316:30GLOBECognition Therapeutics Presents Complete EEG Findings from..
10/16/202307:30GLOBECognition Therapeutics Presents New Data at CTAD Conference..
9/12/202307:00EDGAR2Form 8-K - Current report
9/07/202307:45GLOBECognition Therapeutics Announces New Conversations Episode..
8/30/202308:00GLOBECognition Therapeutics Announces Participation in Upcoming..
8/24/202307:00EDGAR2Form 8-K - Current report
8/08/202307:16EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
8/08/202307:05EDGAR2Form 8-K - Current report
8/08/202307:00GLOBECognition Therapeutics Reports Second Quarter 2023 Financial..
8/02/202307:30GLOBECognition Therapeutics to Report Second Quarter 2023 Results..
7/11/202307:30GLOBECognition Therapeutics Announces Dosing of First Patient in..
7/05/202307:30GLOBECognition Therapeutics and the Alzheimer's Clinical Trials..
6/28/202307:00GLOBECognition Therapeutics Announces Positive Topline Results..
6/27/202319:17GLOBECognition Therapeutics to Host Call and Webcast to Discuss..
6/20/202307:30GLOBECognition Therapeutics Invited to Participate on Panel..
6/02/202307:30GLOBECognition Therapeutics Continues Investor Engagement in June..
5/23/202307:30GLOBECognition Therapeutics Latest Episode of “Conversations”..
5/18/202307:30GLOBECognition Therapeutics Publishes Clinical Evidence that..
5/04/202316:05GLOBECognition Therapeutics Reports First Quarter 2023 Financial..
5/01/202307:30GLOBECognition Therapeutics Appoints John Doyle to the Role of..

Your Recent History

Delayed Upgrade Clock